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Mycobacterium tuberculosis is the species of bacteria that 
is the causative agent of tuberculosis. Those at high risk 
for tuberculosis include the elderly, infants, and individuals 
already infected with a disease that affects the immune 
system. This makes M. tuberculosis a common source 
of nosocomial infections, and the emergence of drug-
resistant strains of the bacteria calls for research into new 
drugs for treatment of infection with M. tuberculosis. One 
possible method of treatment involves targeting a putative 
exopolyphosphatase encoded by the gene Mt1054. An 
Escherichia coli homologue of this protein regulates the 
levels of polyphosphate and guanosine 5’-triphosphate 
3’-diphosphate (pppGpp), both of which act as signaling 
molecules during amino acid starvation. The presence of 
the protein encoded by Mt1054 has been shown to affect 
biofilm formation and sliding motility in Mycobacterium 
smegmatis. In this research, Mt1054 will be inserted into the 
expression plasmid pET30. The protein will be expressed 
and purified, and enzymatic assays will be conducted on the 
purified protein in order to determine its phosphohydrolytic 
enzyme activity. This information can be used in the 
future to develop methods of modulating M. tuberculosis 
exopolyphosphatase activity. By doing so, clinicians may 
be able to trick the bacteria out of going into stationary 
phase and developing biofilms. Disrupting the ability 
of M. tuberculosis to form biofilms could increase the 
susceptibility of this bacterium to antibiotics and decrease 
the mortality rate of this potentially deadly disease.
Research advisor David A. Sanders writes, “There will 
be 9,000,000 new cases and 1,400,000 deaths from 
tuberculosis this year. Brandt Lydon is investigating the 
function of a protein that makes the decision between 
rapid and slow growth of the bacterium Mycobacterium 
tuberculosis that causes tuberculosis. His independent 
research may contribute to increasing the susceptibility 
of the bacterium to antibiotics.”
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